Abcam: Shareholders Board Members Managers and Company Profile | GB00B6774699

Business description: Abcam

Abcam plc is a global life science company. The Company serves customers at the forefront of life science research through the identification, development, and distribution of biological reagents. Its products are used by researchers around the world to study biological pathways critical for scientific research, diagnostics, and drug discovery. It offers a selection of products in its catalogue to support research on proteins in biological pathways. Its principal catalogue product lines include primary and secondary antibodies, conjugated antibodies and conjugation kits, and singleplex immunoassays. It offers a range of peptides and proteins, which include cytokines, growth factors, and enzymes. It offers a range of knockout cell lines and lysates, which are used for its in-house validation needs and are also made available to its customers for their own research. It offers a variety of other products, including cellular activity kits, biochemicals and cell signaling pathway tools.

Number of employees: 1,760

Sales by Activity: Abcam

Fiscal Period: December	2019 (GBP)	2020 (GBP)	2021 (GBP)	2022 (GBP)
Sales of Antibodies and Related Products	260M	260M	315M	362M

See all business segments

Geographical breakdown of sales: Abcam

Fiscal Period: December	2019 (GBP)	2020 (GBP)	2021 (GBP)	2022 (GBP)
The Americas	-	112M	130M	162M
EMEA	-	69.3M	84.3M	90.1M
China	39.9M	39.5M	58.2M	62.9M
Rest of Asia	-	20M	23.8M	28.3M
Japan	16.9M	18.8M	18.7M	17.9M
United Kingdom (UK)	13.6M	-	-	-
Other Countries	58.7M	-	-	-
Germany	15.2M	-	-	-
United States (US)	116M	-	-	-

See all geographic segments

Executive Committee: Abcam

Manager	Title	Age	Since
Alan Hirzel CEO	Chief Executive Officer	58	2014-09-08
Markus Lusser PSD	President	58	2024-03-17
Michael Baldock DFI	Director of Finance/CFO	62	2020-02-02
Tommy J. Thomas IRC	Investor Relations Contact	-	2022-06-26
Emma Sceats SAM	Sales & Marketing	-	-

See ABCAM governance

Composition of the Board of Directors: Abcam

Director	Title	Age	Since
Alan Hirzel BRD	Director/Board Member	58	2013-12-31
Mara Aspinall BRD	Director/Board Member	63	2015-09-13
Giles Kerr BRD	Director/Board Member	67	2018-12-11
Michael Baldock BRD	Director/Board Member	62	2020-02-02
Luba Greenwood BRD	Director/Board Member	47	2022-09-11
Markus Lusser BRD	Director/Board Member	58	2025-07-28

Composition of the Board of Directors

Company details: Abcam

Abcam Plc

Discovery Drive

CB2 0AX, Cambridge

+44 12 2369 6000

http://www.abcam.com

Biopharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+2.09%	+1.31%	+23.51%	-6.22%	67.6B
UCB	+0.55%	-5.20%	+39.70%	+195.66%	51.32B
SAMSUNG BIOLOGICS CO.,LTD.	+1.10%	+38.30%	+38.30%	+38.30%	42.97B
CSL LIMITED	+0.16%	-2.85%	-50.72%	-52.88%	40.81B
BIOGEN INC.	+3.66%	+2.46%	+58.66%	-26.79%	29.12B
MODERNA, INC.	-4.33%	-14.30%	+104.65%	-46.48%	27.09B
INCYTE CORPORATION	+1.19%	-1.93%	+67.89%	+90.29%	22.99B
INNOVENT BIOLOGICS, INC.	-2.94%	+9.28%	+9.66%	+190.29%	21.55B
SWEDISH ORPHAN BIOVITRUM AB	+1.38%	-3.97%	+62.47%	+123.42%	16.38B
Average	+0.32%	-0.61%	+39.35%	+56.18%	35.54B
Weighted average by Cap.	+0.62%	-0.77%	+32.95%	+47.74%